Načítá se...

Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial

Primary graft dysfunction (PGD) and non-function (PNF) happen in 8.7-24.7% and 0.9-7.2% of liver transplant recipients, respectively. These phenomena increase treatment cost and patients’ death. This study assessed the effect of L-carnitine supplementation on the incidences of PNF/PGD in liver trans...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Res Pharm Sci
Hlavní autoři: Khajeh, Behrouz, Dashti-Khavidaki, Simin, Nasiri-Toosi, Mohsen, Mohammadi, Keyhan, Jafari, Atefeh
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer - Medknow 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937745/
https://ncbi.nlm.nih.gov/pubmed/32038730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.272537
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!